{
    "Trade/Device Name(s)": [
        "CEDIA\u00ae Tacrolimus Assay",
        "CEDIA\u00ae Tacrolimus Calibrators"
    ],
    "Submitter Information": "Microgenics Corporation",
    "510(k) Number": "K050206",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MLM",
        "JIT"
    ],
    "Summary Letter Date": "March 15, 2005",
    "Summary Letter Received Date": "January 28, 2005",
    "Submission Date": "January 27, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1678"
    ],
    "Regulation Name(s)": [
        "Tacrolimus test system"
    ],
    "Analyte Class(es)": [
        "transplant",
        "tdm",
        "chemistry"
    ],
    "Analyte(s)": [
        "Tacrolimus"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay"
    ],
    "Methodologies": [
        "Homogeneous enzyme immunoassay",
        "Recombinant DNA technology"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for CEDIA Tacrolimus Assay and Calibrators using enzyme immunoassay for quantitative tacrolimus determination in whole blood of transplant recipients",
    "Indications for Use Summary": "Intended for quantitative determination of tacrolimus in whole blood as an aid in management of kidney and liver transplant recipients receiving tacrolimus therapy, with calibrators for assay calibration",
    "fda_folder": "Clinical Chemistry"
}